Questions following the DESTINYBreast trials

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=iKf_CNIP-qA

Janice Wing-Hang Tsang, MBBS, MRCP, FRCP, University of Hong Kong, Hong Kong, China, discusses the DESTINY-Breast-01—03 studies (NCT03248492, NCT03523585, NC...

Event: ESMO 2023, Speaker: Janice Wing-Hang Tsang, Format: Interview, Institution: University of Hong Kong, Subject: Breast Cancer, Triple-Negative Breast Cancer, TNBC, Field: Immuno-oncology, Field: Treatment, Field: Trial Updates, Trial: DESTINY-01, NCT03248492, Trial: DESTINY-02, NCT03523585, Trial: DESTINY-03, NCT03529110, Medicines: Trastuzumab deruxtecan, Medicines: Antibodies, Medicines: Checkpoint Inhibitors, Targeted Treatment, Immunotherapy, HER2, Brain Metastasis
#############################